why choose us

First received: August 7, 2022

Clinical Trial: Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Benign Prostatic Hyperplasia
Overactive Bladder

Study Type: Interventional


Official Title: Efficacy of Tadalafil and Solifenacin Versus Tamsulosin and Solifenacin Combination Therapy for the Treatment of Benign Prostatic Hyperplasia With Overactive Bladder: A Randomized Controlled Trial

Brief Summary: The investigators will compare the efficacy and safety of tadalafil/solifenacin combination therapy versus tamsulosin/solifenacin combination therapy for the treatment of BPH/OAB in a randomized controlled trial (RCT).

Read more